Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...

RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti

September 13, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Sept. 13 /- RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ).  The L-Ti was previously cleared as an interbody fusion device. RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about...

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015

September 13, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015 -- DALLAS, September 13, 2010 /-

Advertisement

Siemens and National Semiconductor Align to Advance Ultrasound Technology

September 13, 2010 5:37 am | News | Comments

Siemens Medical Solutions USA, Inc. and National Semiconductor Corporation announce a wide-ranging strategic alliance to advance ultrasound technology, creating ultrasound imaging systems...

Debiopharm Group™ and Aurigene Nominate Development Candidate

September 13, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

LAUSANNE, Switzerland, and BANGALORE, India, Sept. 13 /- Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies...

Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents

September 10, 2010 5:36 pm | by Covidien | News | Comments

ST. LOUIS, Sep 10, 2010 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or...

Covance to Present at Morgan Stanley Global Healthcare Conference

September 10, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept. 10 /- Covance Inc. (NYSE: CVD ) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 p.m. ET.  Investors may access a live webcast of the presentation at www.covance.com .  In order...

FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women

September 10, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

WILMINGTON, Del., Sept. 10 /- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection , replacing the previously approved monthly dose of 250mg, for the treatment of hormone...

Advertisement

Massachusetts Regional Extension Center Selects Greenway's PrimeSuite

September 9, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

CARROLLTON, Ga., Sept. 9 /- The Massachusetts e-Health Institute, a division of the Massachusetts Technology Collaborative, has selected Greenway Medical Technologies, Inc.'s single-database electronic health record (EHR), practice management and interoperability solution PrimeSuite®...

New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting

September 9, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 9 /- Live video detailing has made a strong comeback after a false start in the early 2000s, according to pharmaceutical and healthcare market research company Manhattan Research's ePharma Physician ® v10.0 study. Physician adoption of live video detailing has more...

Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection

September 9, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Sept. 9 /- Medizone International, Inc. (OTC Bulletin Board, OTCQB: MZEI) announces it has filed an additional international patent application covering recent developments in its variant of AsepticSure™ designed for government use in bio-terrorism countermeasures....

Misonix Announces New Distribution Agreement For Spain

September 9, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Sept. 9 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Dismeval, s.l.,  based in...

Streamline Health Document Workflow Solutions Purchased By Tampa, Florida-Based Hospital

September 8, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Sept. 8 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of...

Advertisement

Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics

September 8, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Sept. 8 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the...

NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel

September 7, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Sept. 7 /- NetMotion Wireless, a leading provider of mobile productivity and management software, announced today that its award winning mobile Virtual Private Network (VPN) solution, Mobility XE, has been deployed by IDEXX to improve the performance of hundreds of mobile workers...

DSM Launches InnoSyn™ Route Scouting Services to Meet Pharmaceutical Company Needs to Outsource R & D

September 7, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Sept. 7 /- DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost...

Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the key Revenue Generators now Available at ReportsandReports

September 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to... -- DALLAS, September 6, 2010 /-

New and Unique Tool Eases the Process of Finding Article Reviewers

September 6, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

New and Unique Tool Eases the Process of Finding Article Reviewers -- AMSTERDAM, September 6, 2010 /-

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders

September 6, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming......

Property Sales Give Biotech Brokers the Jitters

September 5, 2010 11:32 pm | by San Diego Business Journal | News | Comments

Experts say the recently announced purchase of three San Diego life sciences buildings by Alexandria Real Estate Equities Inc., already among the dominant players in local biotech real estate, marks a continuing trend toward consolidation, and could also signal a spree of acquisitions...

China-Biotics Announces September 20 Investor Day Schedule

September 3, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

China-Biotics Announces September 20 Investor Day Schedule -- SHANGHAI, Sept. 3 /PRNewswire-Asia-FirstCall/ --

NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of 'AMP' Rule Currently Blocked by Injunction

September 3, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Sept. 3 /PRNewswire-USNewswire/ -- The following is a statement issued today by National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson, IOM, CAE, and National Community Pharmacists Association (NCPA) Acting Executive Vice President and CEO...

Medical Affairs Report Outlines Resource Needs for Group Success

September 3, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Sept. 3 /- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas such as clinical development, scientific publications, KOL development, and medical education. These areas must...

Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend

September 3, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock... -- JERUSALEM, September 3, 2010 /- <...

ForteBio Announces Launch of Protein G Biosensor for Use on Company's Octet® Instruments

September 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

MENLO PARK, Calif., Sept. 3 /- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantification...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading